Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0017638 (
glioma
)
30,880
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Glioblastoma multiforme (GBM) is the most common primary brain tumor in adults. The extraordinary invasion of human GBM into adjacent normal brain tissues contributes to treatment failure. However, the mechanisms that control this process remain poorly understood. Increasing evidence has demonstrated that microRNAs are strongly implicated in the migration and invasion of GBM. In this study, we found that microRNA-98 (miR-98) was markedly downregulated in human
glioma
tissues and cell lines. Functional experiments indicated that restored expression of miR-98 attenuated
glioma
cell invasion and migration, whereas depletion of miR-98 promoted
glioma
cell invasion and migration. Subsequent investigation showed that
pre-B-cell leukemia homeobox 3
(
PBX3
), an important transcription factor that controls tumor invasion, was a direct and functional target of miR-98 in GBM cells. Consistently, an orthotopic mouse model also demonstrated the suppressive effects of miR-98 overexpression on tumor invasion and
PBX3
expression. Silencing of
PBX3
using small interfering RNA inhibited the migratory and invasive capacities of
glioma
cells, whereas reintroduction of
PBX3
into
glioma
cells reversed the anti-invasive function of miR-98. Furthermore, depletion of
PBX3
phenocopied the effects of miR-98 overexpression in vivo. Finally, quantitative real-time polymerase chain reaction results showed that miR-98 was negatively correlated with
PBX3
expression in 24
glioma
tissues. Thus, we propose that
PBX3
modulation by miR-98 has an important role in regulating GBM invasion and may serve as therapeutic target for GBM.
...
PMID:MicroRNA-98 Attenuates Cell Migration and Invasion in Glioma by Directly Targeting Pre-B Cell Leukemia Homeobox 3. 2812 8